Read further: Therapeutic Potential of FPR Agonist Cmpd17b in Hypertension-Induced End-Organ Damage
You may also like
Real-World Effectiveness of Nirsevimab in Preventing...
Comparison of Hypotension-Avoidance and Hypertension...
Portfolio Diet Reduces CVD Mortality and Risk Factors...
Increased Cardiac Mortality in Massachusetts During...
Tracking Early Cardiac Development: Insights from Live...
Cardiac Digital Twins: Advancing Personalized Insights...
About the author
